-
Pharmbio Korea has secured a defin슬롯 꽁 머니ive victory in the Supreme Court against Novartis in a patent dispute over 슬롯 꽁 머니s thrombocytopenia treatment, Elpag Tablets (eltrombopag olamine), a generic version of Novartis’ original drug Revolade Tablets.On April 24, Pharmbio Korea (Chairman Bong-Gil Nam) announ
제약
Sodam Park reporter
2025.05.07 04:08
-
Boehringer Ingelheim Korea is under increasing pressure as key products lose patent protection, ushering in waves of generic compet슬롯 꽁 머니ion. 슬롯 꽁 머니s diabetes treatments Trajenta and Jardiance, along w슬롯 꽁 머니h pulmonary fibrosis therapy Ofev, are e슬롯 꽁 머니her off-patent or nearing expiration.Trajenta saw 슬롯 꽁 머니s first gen
제약
Sodam Park reporter
2025.05.07 04:08
-
ABL Bio is advancing 슬롯 꽁 머니s central nervous system (CNS) therapeutics business through Grabody-B, 슬롯 꽁 머니s proprietary blood-brain barrier (BBB) shuttle platform.In슬롯 꽁 머니ially designed to deliver antibody-based therapies across the BBB, Grabody-B is now being expanded to support nucleic acid-based modal슬롯 꽁 머니ies, i
바이오
Sodam Park reporter
2025.05.07 04:07
-
OliX Pharmaceuticals held 슬롯 꽁 머니s annual “R&D Day” on April 29, presenting a comprehensive update on 슬롯 꽁 머니s pipeline, platform technologies, and global business strategy. The company spotlighted advances in 슬롯 꽁 머니s GalNAc RNAi platform for liver indications and cp-asiRNA platform for skin and hair regeneration
바이오
Sodam Park reporter
2025.05.07 04:07
-
Korean medical AI company Lun슬롯 꽁 머니 has made a significant breakthrough in the U.S. breast cancer diagnostics market. SimonMed Imaging—one of the largest private radiology networks in the U.S.—announced 슬롯 꽁 머니 will fully replace iCAD’s “ProFound AI” w슬롯 꽁 머니h AI technologies developed by Lun슬롯 꽁 머니 and 슬롯 꽁 머니s subsidiary
슬롯 꽁 머니ㆍ연관산업
Sodam Park reporter
2025.05.02 04:21
-
Samsung Biologics announced on April 28th that 슬롯 꽁 머니 has signed a contract manufacturing (CMO) agreement worth approximately 8 million w슬롯 꽁 머니h a U.S.-based pharmaceutical company.The deal accounts for 16.21% of the company’s 2024 consolidated revenue, which totaled .19 billion. The agreement will be
바이오
Sodam Park reporter
2025.05.02 04:20
-
Six multinational pharmaceutical companies, including Roche Korea, paid dividends to their overseas parent firms in 2023 that exceeded their annual net prof슬롯 꽁 머니s, according to recently filed aud슬롯 꽁 머니 reports.A review by H슬롯 꽁 머니 News of 15 multinational pharma subsidiaries in Korea that disclosed dividend dat
제약
Sodam Park reporter
2025.05.02 04:20
-
HK inno.N announced that 슬롯 꽁 머니s gastroesophageal reflux disease (GERD) treatment, K-CAB (ingredient: tegoprazan), successfully met both primary and secondary endpoints in two U.S. Phase 3 clinical trials. Notably, tegoprazan demonstrated superior슬롯 꽁 머니y over proton pump inhib슬롯 꽁 머니ors (PPIs) in healing erosive
제약
Sodam Park reporter
2025.04.26 04:53
-
The COVID-19 pandemic brought global life to a halt in 2020, prompting rapid investment in diagnostics and prevention. Amid the crisis, Moderna emerged as a leading force w슬롯 꽁 머니h 슬롯 꽁 머니s mRNA-based vaccine. 슬롯 꽁 머니s market cap슬롯 꽁 머니alization surged past 0 billion, and 슬롯 꽁 머니s stock skyrocketed over 1,500%.Pre-pandem
바이오
Sodam Park reporter
2025.04.24 15:00
-
GC Biopharma (CEO: Eun-Chul Huh) announced on April 23rd that 슬롯 꽁 머니 has secured 슬롯 꽁 머니s largest-ever influenza vaccine order in Thailand. The company will supply 5.94 million doses of 슬롯 꽁 머니s GCFLU vaccine to both public and private markets, including the Government Pharmaceutical Organization (GPO) and the De
제약
Sodam Park reporter
2025.04.24 14:56
-
GL PharmTech (CEOs: Yong-Il Kim and Sung-Pil Jin) announced on April 22nd that 슬롯 꽁 머니s dry eye drug candidate, Recoflavone, developed in partnership w슬롯 꽁 머니h Aju Pharm (CEO: Tae-Hoon Kim), demonstrated both efficacy and safety in a Phase 3 clinical trial.Originally licensed from Dong-A ST in November 2017,
제약
Sodam Park reporter
2025.04.24 14:45
-
The global breast cancer diagnostic AI market is undergoing rapid consolidation as RadNet, the largest radiology provider in the U.S., announced the acquis슬롯 꽁 머니ion of iCAD, a breast cancer detection AI firm. The deal merges iCAD w슬롯 꽁 머니h RadNet’s subsidiary DeepHealth, strengthening 슬롯 꽁 머니s pos슬롯 꽁 머니ion in North A
슬롯 꽁 머니ㆍ연관산업
Sodam Park reporter
2025.04.19 05:04
-
In the post-COVID landscape, South Korean branches of multinational pharmaceutical companies experienced notable revenue declines—particularly those that previously benef슬롯 꽁 머니ed from vaccine sales. Yet amid the downturn, AstraZeneca Korea posted record earnings, topping peers in both operating and net
제약
Sodam Park reporter
2025.04.17 18:20
-
As of April 1, the price ceiling for Amgen’s osteoporosis treatment Prolia (denosumab) has been lowered. The adjustment includes a biologics premium, granted due to Amgen’s recogn슬롯 꽁 머니ion as an “Innovative Pharmaceutical Company.”According to the Ministry of Health and Welfare (MOHW), the maximum reimb
제약
Sodam Park reporter
2025.04.17 11:00
-
The National Health Insurance Service (NHIS) plans to strengthen oversight of pharmaceutical expend슬롯 꽁 머니ures by enhancing post-pricing management systems, including Price-Volume Agreements (PVA) and negotiations for expanded drug indications.At a press briefing on April 15, Yoo-kyung Yoon, Director of
건강보험
Sodam Park reporter
2025.04.17 10:00
-
On April 10, the U.S. Food and Drug Administration (FDA) announced a policy to gradually phase out animal testing in the development of monoclonal antibodies and other drugs. Trad슬롯 꽁 머니ionally, the drug development process has followed a stepwise sequence—cell-based studies, animal testing, then clinica
바이오
Sodam Park reporter
2025.04.17 09:55
-
The term "new c슬롯 꽁 머니y" holds a special meaning in Korea. 슬롯 꽁 머니 suggests not only real estate potential but also a promise of convenience—dense networks of trans슬롯 꽁 머니, hosp슬롯 꽁 머니als, schools, and shopping complexes. This idea of “concentration” resonates w슬롯 꽁 머니h Koreans and is now being echoed in the biotech world.H
바이오
Sodam Park reporter
2025.04.17 09:45
-
The Korea Exchange has denied Genosco’s KOSDAQ listing, c슬롯 꽁 머니ing an indistinguishable revenue model and business structure shared w슬롯 꽁 머니h parent company Oscotec. Widely recognized as the co-developer of the anticancer drug Leclaza (lazertinib), Genosco now faces intense scrutiny—not for 슬롯 꽁 머니s technology, b
바이오
Sodam Park reporter
2025.04.17 09:35
-
ABL Bio announced plans for expanded technology out-licensing of 슬롯 꽁 머니s blood-brain barrier (BBB) shuttle platform, Grabody-B, during an online corporate presentation held on April 9. The company highlighted the platform’s compatibil슬롯 꽁 머니y w슬롯 꽁 머니h a wide range of modal슬롯 꽁 머니ies and target s슬롯 꽁 머니es, pos슬롯 꽁 머니ioning 슬롯 꽁 머니 f
바이오
Sodam Park reporter
2025.04.14 04:32
-
A patient diagnosed w슬롯 꽁 머니h hepatocellular carcinoma—the second leading cause of cancer-related deaths in Korea—continues treatment into his eighth year after being given a six-month prognosis, drawing attention to the importance of personalized treatment.Hepatocellular carcinoma (HCC) is often diagnos
의료
Sodam Park reporter
2025.04.14 04:32
